BASINGSTOKE, United Kingdom--(BUSINESS WIRE)--Valeant Pharmaceuticals Ltd. today announced that it has signed an agreement with Intendis GmBH whereby Valeant will sell a range of Intendis dermatological products, including Finacea®, a topical treatment for rosacea, which was launched on September 18, 2006, in the United Kingdom (U.K.). This distribution agreement, which was effective on September 1, 2006, enables Valeant to broaden its offering of dermatological products in the U.K.
